baber/WOPTO huggingface dataset:
Patent CS-199609-B2 (CS)
Title: Method of producing 6-methyl-8-isocyanmethyl ergoline
Inventor: KORNFELD EDMUND C
IPC: A61K31/48
Filed: 1975-11-20
Abstract: 1526835 Ergoline derivatives ELI LILLY & CO 27 Nov 1975 [6 Dec 1974] 48901/75 Heading C2C Novel compounds II in which R is CH 2 SOCH 3 , NO 2  or NC, and non- toxic, pharmaceutically acceptable acid addition salts thereof, are prepared by (a) reacting a compound III in which Q is Cl, Br, I, methanesulphonyloxy or p-toluenesulphonyloxy, with dimethylsulphoxide in the presence of a strong base to form a compound II in which R is CH 2 SOCH 3 , or with sodium nitrite in the presence of an organic solvent to form a compound II in which R is NO 2 , or (b) reacting a compound IV  with methanesulphonyl chloride or chloral, and treating the resulting compound II in which R is NHSO 2 CH 3  or NHCHO with thionyl chloride, phosphorus oxychloride or phosgene in the presence of a base to give a compound II in which R is NC, and optionally reacting a compound II with an acid to form the corresponding acid addition salt.  Pharmaceutical compositions having prolactin inhibition activity, for oral or parenteral administration, comprise a compound of the invention together with a pharmaceutical carrier.
Patent JP-H0749252-B2 (JP)
IPC: B60Q1/06
Filed: 1990-01-12
Abstract: PURPOSE:To eliminate excessive play as well as absorb a fluctuation in sizes by providing two spherical seats on a bearing wherein one spherical seat holds the spherical head of the output rod of a driving mechanism and the other seat holds the spherical head of a coupling lever providing on the side of a head lamp unit. CONSTITUTION:An optical axis adjusting apparatus 30 for adjusting leveling of a head lamp unit 13 includes a motor 31 supported by a bracket 32 provided at the widthwise center on the upper end of a mounting ring 25 and is equipped with a spherical head 34 on the front end of the output rod 33 of a motor 31. A coupling lever 36 provided with a spherical head 39 at the tip is placed on a mounting ring 26 attached to a retaining ring of the side of the head lamp unit 13 facing to the output rod 33, while the coupling lever 36 is coupled to the output rod 33 with a bearing 37. The bearing 37 consists of semispherical seats 46, 47 in a chamber partitioned into front and rear by means of partition 45, wherein the respective spherical heads 34, 39 are fitted into the respective spherical seats 46, 47 so that they can made relative turning motion.
Patent JP-S6148823-B2 (JP)
IPC: C07C241/00
Filed: 1983-01-25
Abstract: A process for the preparation of a tertiary butyl hydrazine hydrohalogenide comprises reacting a hydrazine salt of a hydrohalogenic acid with tertiary butanol in the presence of a hydrazine dihydrohalogenide or a hydrogen halide. This tertiary butyl hydrazine halogenide is neutralized by an alkali, the neutralization product is distilled and free tertiary butyl hydrazine is then recovered.
Patent AU-555600-B2 (AU)
Title: Polyurethane casting material
Inventor: YOON HEE KYUNG
IPC: A61L15/12
Filed: 1983-02-09
Granted: 1986-10-02
Abstract: An improved polyurethane orthopaedic cast bandage is disclosed. The bandage is a polyurethane prepolymer coated on an open-weave, fibrous substrate. The prepolymer contains dimorpholinodiethylether as a catalyst which gives the cast bandage increased shelf stability and excellent set time.
Patent AU-599206-B2 (AU)
Title: Hydrogen peroxide-releasing tooth powder
Inventor: WINSTON ANTHONY E
IPC: A61K8/21
Filed: 1988-02-19
Granted: 1990-07-12
Abstract: A stable, palatable and safe hydrogen peroxide releasing tooth powder composition containing sodium bicarbonate and sodium percarbonate in combination with flavoring agents, sweeteners, fluoridating agents, additional abrasives, surfactants and/or additional adjuvants.
Patent AU-780715-B2 (AU)
Title: Encapsulated stent preform
Inventor: JAYARAMAN SWAMINATHAN
IPC: A61F2/02
Filed: 2000-11-16
Granted: 2005-04-14
Abstract: The invention relates to a stent preform for implantation in a body lumen. The stent preform includes an elongated metal core having first and second core ends, a contact surface, and a solid cross-section, and a hollow outer sheath made of a biocompatible polymer and having first and second sheath ends, caps disposed on the sheath ends, and an interior surface. The outer sheath surrounds and contacts the contact surface of the core to prevent the core from directly contacting the body lumen. In another embodiment, the biocompatible polymer of the outer sheath is formed of a heat-shrinkable polymer material, and the elongated core is formed of a shape-memory alloy. In another embodiment, the outer sheath is formed from a polymer tape.
Patent AU-756261-B2 (AU)
Title: A distributor device
Inventor: DENTER FRIEDRICH WILHELM
IPC: H02G3/04
Filed: 2000-02-07
Granted: 2003-01-09
Abstract: The device (10) has a first wire guide channel which runs from one side of the housing (12) to the front of the housing. A second channel runs from the opposite side to the front of the housing. The first channel has a greater cross-section than the second channel.
Patent AU-690202-B2 (AU)
Title: Process for producing cellulose shaped bodies
Inventor: KALT WOLFRAM
IPC: D01F2/02
Filed: 1995-02-01
Granted: 1998-04-23
Abstract: PCT No. PCT/AT95/00022 Sec. 371 Date Aug. 14, 1995 Sec. 102(e) Date Aug. 14, 1995 PCT Filed Feb. 1, 1995 PCT Pub. No. WO95/23885 PCT Pub. Date Sep. 8, 1995The invention is concerned with a process for the production of cellulose molded bodies. This process has the following steps: (A) dissolving cellulose in an aqueous solution of a tertiary amine-oxide to produce a moldable cellulose solution, (B) molding said cellulose solution and conducting said molded cellulose solution into an aqueous precipitation bath, wherein the cellulose is precipitated, thus producing a molded body and a spent precipitation bath, and (C) purifying said spent precipitation bath by contacting said precipitation bath with an ion exchanger, thus producing a purified aqueous amine-oxide solution which, optionally after concentration, is re-used again in step (A) as a cellulose solvent. In this process, the ion exchanger comprises a cellulose carrier which has attached groups which are capable of exchanging ions.
Patent AU-699947-B2 (AU)
Title: Spinel based catalysts for reducing emissions of oxides of nitrogen
Inventor: BARTHE PHILIPPE
IPC: B01J23/14
Filed: 1995-04-03
Granted: 1998-12-17
Abstract: The use of a homogeneous catalyst of spinel structure and formula ZnAl2O4 or an oxide of spinel structure (normal or inverse) other than ZnAl2O4, for the treatment of exhaust gases with a high O2 content, is claimed. Pref. the oxide of spinel structure (normal or inverse) corresp. to the formula:- AB2O4 A = at least one element from gps. IIa, IIb, IIIb, IVb and Vb or any transition element. B = at least one element from gps. IVa, VIa, VIIa, VIIIa, Ib to Vb. Esp., A = Mg, Ti, Mn, Fe, Co, Ni, Cu, Zn, or Sn, and B = Ti, Mn, Cr, Fe, Co, Ni, Cu, Zn, Al, Ga, In, Sn or Sb. More pref, B = Al or Ga.
Patent AU-739233-B2 (AU)
Title: Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides
Inventor: DEMICHELE STEPHEN J
IPC: A23L1/30
Filed: 1998-12-04
Granted: 2001-10-04
Abstract: This invention relates to a method for enhancing the absorption of oil soluble (lipophilic) compounds such as oil soluble vitamins, hormones, nutrients and drugs in an animal. The inventive method comprises administering a lipophilic compound in conjunction with a structured glyceride component characterized in that at least 40% of the glyceride species have: (i) about 33 to 70 wt. % of acyl moieties having 4 to 12 carbon atoms; (ii) about 30 to 67 wt. % of acyl moieties having more than 12 carbon atoms; and (iii) an equivalent carbon number greater than 30 and less than 48. This invention also relates to compositions suitable for administrating to an animal comprising a lipophilic compound and a structured glyceride component characterized in that at least 40% of the glyceride species have: (i) about 33 to 70 wt. % of acyl moieties having 4 to 12 carbon atoms; (ii) about 30 to 67 wt. % of acyl moieties having more than 12 carbon atoms; and (iii) an equivalent carbon number greater than 30 and less than 48. The method and compositions of the invention are especially suited for animals that suffer from lipid malabsorption conditions such as Crohn's disease, Cystic fibrosis, and short bowel syndrome.
Patent AU-608329-B2 (AU)
Title: Chewing gum having a controlled sweetness
Inventor: YATKA ROBERT
IPC: A23G4/10
Filed: 1988-05-11
Granted: 1991-03-28
Abstract: A chewing gum composition having a controlled sweetness comprising a chewable gum base and an effective amount of sweetener comprising sucralose. The chewing gum contains sucralose in an amount such that within the initial 2 minutes of chewing, said sucralose releases from said gum at a rate less than about 8 sucrose equivalents per minute, and at about 10 minutes of chewing, said sucralose releases from said gum at a rate greater than about 3 sucrose equivalents per minute. The chewing gum may also contain a fast release sweetener or an additional amount of sucralose treated to act as a fast release sweetener. Various methods of manufacturing the chewing gum are also provided.
Patent AU-705673-B2 (AU)
Title: A method of and device for producing energy
Inventor: POMPEI LADISLAO
IPC: F23K5/12
Filed: 1995-03-03
Granted: 1999-05-27
Abstract: The application concerns a method and a device for producing heat energy by contacting water with hot oil in a reaction vessel (11), which leads to a violent reaction outputting a flame-like eruption of very hot gases, the generated heat energy being more than can be obtained by simply burning only the oil.
Patent AU-694766-B2 (AU)
Title: Automatic suturing and ligating device
Inventor: EGAN THOMAS D
IPC: A61B17/04
Filed: 1995-02-16
Granted: 1998-07-30
Abstract: A device and method of suturing closed an opening and ligating a vessel or duct comprising removable tissue puncturing means (22) or vessel surrounding means establishing a continuous channel (24) through said tissue or around said vessel from each side. A completed channel (24) is formed and suture material (26) is threaded through the channel making a complete loop. The thread is secured at an anvil (30) independent from said puncturing/surrounding means. The puncturing/surrounding means is retracted leaving the thread, which is then tensioned closing the opening or occluding the vessel. The suture thread is secured and cut, forming a closed loop with overlapping ends. An energy transmitting device (38) melts the suture thread ends together forming a weld. The anvil (30) is removed leaving a knot-free completed stitch or ligature.
Patent AU-726379-B2 (AU)
Title: Recombinant ribonuclease proteins
Inventor: RYBAK SUSANNA M
IPC: A61K38/00
Filed: 1997-02-19
Granted: 2000-11-02
Abstract: The invention relates to ribonucleases derived from a native ribonuclease found in the oocytes of Rana pipiens. Various humanized and recombinant forms of these molecules are described as well as uses for them.
Patent AU-778251-B2 (AU)
Title: Filtration device for liquids
Inventor: HOFMANN UWE
IPC: C02F1/00
Filed: 2000-11-02
Granted: 2004-11-25
Abstract: A filtration device for liquids is provided and includes a filtration beaker filled with a filtration material and a lid. The lid is connected to the filtration beaker in a liquid-tight manner to define an inner volume, and includes at least one liquid inlet and at least one air vent. A sieve-like textile fabric is disposed in between the filtration beaker and the lid. In order to guarantee secure operation and ensure a good retaining effect with respect to particles having a size of approximately 200 micrometers at different filtration-material fill heights in the filtration beaker, the sieve-like textile fabric has at least one formed part protruding into the inner volume of the lid, whereby air can be found on both sides of the part of the textile fabric which is located farthest away from the filtration beaker.
Patent AU-663887-B2 (AU)
Title: Two piece insert moulded spout and cap for fixed over a container opening
Inventor: MOCK ELMAR
IPC: B29C45/16
Filed: 1992-09-11
Granted: 1995-10-26
Abstract: PCT No. PCT/CH92/00188 Sec. 371 Date May 14, 1993 Sec. 102(e) Date May 14, 1993 PCT Filed Sep. 11, 1992 PCT Pub. No. WO93/05945 PCT Pub. Date Apr. 1, 1993.A closure unit for a container for storing and handling flowable products is made from at least two different thermoplastic materials, the different materials fulfilling different functions. A basic thermoplastic material (A.2) is used for sealing against the container (G.2), and an area made of another different thermoplastic material (B.2,C) is provided to fulfill additional sealing functions, to increase mechanical stability, to have a reduced permeability, and to provide increased elasticity for additional opening and closing and/or absorption characteristics. The closure unit is produced by a multimaterial injection molding process, so that contact surfaces between the different thermoplastic materials can be interconnected by reversible or irreversible positive engagement and/or by more or less pronounced melting into one another. The closure unit is in two parts and comprises a pouring part (1.2) and a closure part (2.2), or is in one part. The two-part closure unit is produced in a single operation in a closed state.
Patent AU-658672-B2 (AU)
Title: Stabilisation of 1,1-dichloro-1-fluoroethane
Inventor: LANTZ ANDRE
IPC: C07C17/42
Filed: 1992-10-09
Granted: 1995-04-27
Abstract: In order to stabilise 1,1-dichloro-1-fluoroethane containing traces of vinylidene chloride, at least one ethylenic hydrocarbon containing at least 4 carbon atoms is added to it.
Patent AU-732705-B2 (AU)
Title: Gene expression in monocytes and macrophages
Inventor: GREAVES DAVID ROBERT
IPC: A61P19/02
Filed: 1997-05-02
Granted: 2001-04-26
Abstract: The invention provides a cloned polynucleotide having the function of a transcriptional regulatory sequence (trs) and comprising: (a) a polynucleotide fragment having at least 70 % identity to the polynucleotide of SEQ ID NO. 2; (b) a polynucleotide which is complementary to the polynucleotide of (a); or (c) a polynucleotide comprising at least 15 sequential bases of the polynucleotide of (a) or (b).
Patent AU-580552-B2 (AU)
Title: Laminar electrical heaters
Inventor: CHAZAN DAVID
IPC: H05B3/58
Filed: 1984-05-10
Granted: 1989-01-19
Abstract: Laminar heaters comprise a laminar heating element sandwiched between two laminar electrodes having substantial electrical resistance along the thickness thereof. The heater has a heating area of irregular shape, and at least one of the electrodes extends over a connection area in which heat is not generated but which provides a shorter and/or more uniform current path to the heat-generating parts of the heater.
Patent AU-691145-B2 (AU)
Title: Novel derivative of kojic acid and its use as a depigmenting agent
Inventor: GALEY JEAN-BAPTISTE
IPC: A61K31/425
Filed: 1997-07-08
Granted: 1998-05-07
Abstract: 5-Hydroxy-4-oxo-4H-pyran-2-ylmethyl 2-oxothiazolidine-4-carboxylate and its salts are new. The claimed preparation of (I) comprises esterifying the alcohol function of kojic acid with L-2-oxothiazolidine-4-carboxylic acid (II), preferably by converting kojic acid to a bromo derivative and reacting this with (II).
Patent AU-561633-B2 (AU)
Title: Tablet with a slow or zero order release rate
Inventor: POWELL DAVID R
IPC: A61K9/22
Filed: 1984-05-31
Granted: 1987-05-14
Abstract: A new class of solid pharmaceutical formulations enables the attainment of slow, zero order in vivo release of a wide range of pharmaceutically active ingredients upon oral administration. A broad range of release rates can be preselected by suitable adjustments of tablet properties. The formulations are based upon control of active ingredient release from the surface of the tablet via a controlled surface erosion mechanism. These compositions comprise:(a) an effective amount in the range of 10-90 wt. % of a pharmacologically active compound having a water solubility (20' C.) of 1/5-1/1000 (w/w);(b) 1-40 wt. % of a compound which is pharmaceutically acceptable in oral compositions and has a water solubility (20° C.) of 1/1-1/40 (w/w);(c) 2-20 wt. % of a compound which is pharmaceutically acceptable in oral compositions and has a water solubility (20° C.) of 1/1-1/10 (w/w);(d) an amount in the range of 0.05-1.0 wt. % of a disintegrating agent for pharmaceutical compositions, at which amount the compound is ineffective as a disintegrating agent;(e) 0.1-2.0wt.. % of a surfactant which is pharmaceutically acceptable in oral compositions; and, as necessary for tablet manufacturing purposes;(f) 1-20 wt. % of a binder which is pharmaceutically acceptable in oral compositions; or(g) 0.5-5.0 wt. % of a die wall lubricant which is pharmaceutically acceptable in oral compositions.
Patent AU-612462-B2 (AU)
Title: Polyketone polymer preparation
Inventor: GEUZE MAARTEN MARINUS
IPC: C08G67/00
Filed: 1989-02-08
Granted: 1991-07-11
Abstract: Preparation of polyketone polymers, wherein a mixture of carbon monoxide with one or more olefinically unsaturated compounds is contacted in a reactor with a solution of a palladium-containing catalyst composition, and wherein the catalyst composition is added stepwise to the reactor according to specified rules.
Patent AU-565532-B2 (AU)
Title: Radiation-polymerisable composition
Inventor: GEISSLER ULRICH
IPC: G03F7/004
Filed: 1984-08-15
Granted: 1987-09-17
Abstract: Disclosed is a radiation-polymerizable mixture which includes a polymerizable compound, a radiation-activatable polymerization initiator and a polymeric binder with lateral cross-linking groups of the formula -CH2OR, wherein R denotes a hydrogen atom or a lower alkyl group, a lower acyl group or a lower hydroxyalkyl group. The mixture is cured by heating after development. Also disclosed is a polymerizable copying material which includes a layer comprising the mixture and a process for producing a solder mask including a laminating step for laminating a photoresist layer which includes the layer.
Patent AU-703161-B2 (AU)
Title: Packaging
Inventor: JASICA KAZIMIERZ STANISLAW
IPC: B65D90/20
Filed: 1995-10-30
Granted: 1999-03-18
Abstract: PCT No. PCT/NZ95/00111 Sec. 371 Date Jul. 9, 1997 Sec. 102(e) Date Jul. 9, 1997 PCT Filed Oct. 30, 1995 PCT Pub. No. WO96/14256 PCT Pub. Date May 17, 1996Packaging particularly for bulk materials can include container flexible container which can be contained and suspended within a lifting cradle (11) and about which lifting cradle (11) and the inner container an outer container can be positioned. The lifting cradle (11) has an outlet (14) so as to coincide with the outlet in the base of the inner container and to enable the discharge of materials from the inner container without the need to remove the lifting cradle (11). Lifting straps (15) can provide a loose connection with connectors from the upper portion of the inner container so that when suspended the weight of the inner container and its contents is taken by the lifting cradle (11) and not by the inner container.
Patent AU-574134-B2 (AU)
Title: Pipe propelling device
Inventor: AKESAKA TOSHIO
IPC: E21D9/00
Filed: 1985-02-22
Granted: 1988-06-30
Abstract: A pipe driving device comprises two sets of triple ram assemblies (12, 14) spaced from each other and arranged in the direction of the pipe (30) motion in a vertical shaft having a reacting shaft wall so that the pipe (30) such as a water supply and or drainage pipe, gas pipe and cable duct can be driven from the vertical shaft. 
<??>To reduce the diameter of the vertical shaft necessary to gain operating space in the vertical shaft, the ram assemblies (12, 14) comprise a plurality of first stage jacks (22, 24) connected to the reacting shaft wall and at least one second stage jack (26), a cylinder (26b) of the second stage jack being connected to cylinders (22b, 24b) of the first stage jacks.
Patent AU-759321-B2 (AU)
Title: Continuous polyamidation process
Inventor: BUSH GREGORY E
IPC: C08G69/26
Filed: 1999-05-26
Granted: 2003-04-10
Abstract: A process for producing a polyamide from dicarboxylic acid monomer and diamine monomer comprises the steps of: (a) mixing molten dicarboxylic acid monomer and molten diamine monomer in equimolar amounts, thereby producing a molten reaction mixture; (b) flowing the reaction mixture through at least one unvented reaction vessel, the residence time of the reaction mixture in the at least one unvented reaction vessel being between about 0.01 minutes and about 30 minutes, thereby forming a first product stream that comprises polyamide and water of polymerization; and (c) flowing the first product stream through at least one vented vessel, whereby water of polymerization is removed, thereby forming a second product stream that comprises polyamide. The process can operate continuously, and there is no need to add water to the dicarboxylic acid, to the diamine, or to the reaction mixture.
Patent AU-618407-B2 (AU)
Title: Carbon monoxide/olefin polymerization with diluent comprising aprotic liquid and water
Inventor: WONG PUI KWAN
IPC: B01J23/24
Filed: 1989-09-27
Granted: 1991-12-19
Abstract: Polymers of carbon monoxide with one or more olefinically unsaturated compounds are prepared by contacting the monomers at an elevated temperature and pressure and in the presence of a diluent made up of a mixture of water and one or more aprotic polar liquids in which the polymers are insoluble or virtually insoluble, with a solution of a catalyst composition on the basis of:     a) a palladium compound,   b) an anion of an acid with a pKa of less than 4, and c) a bisphosphine of the general formula (R<1>)2P-R-P(R<1>)2, wherein R<1> represents an optionally polar-substituted aromatic hydrocarbyl group and R is a bivalent organic bridging group containing at least two carbon atoms in the bridge. t
Patent AU-622708-B2 (AU)
Title: Fibroblast growth factor antagonists
Inventor: BAIRD ANDREW JACQUES
IPC: C12R1/19
Filed: 1989-09-27
Granted: 1992-04-16
Abstract: Antagonists to bovine pituitary fibroblast growth factor, a l46 amino acid residue polypeptide, are produced. These antagonists are between 4 and 45 residues in length, are characterized by their ability to a) interact with the FGF receptor and/or b) bind heparin and/or c) inhibit and therefore modulate endothelial cell growth. They include either the four residue sequence which forms basic FGF(36-39), namely Pro-Asp-Gly-Arg, or the four residue sequence which constitutes basic FGH(l07-ll0), namely Arg-Ser-Arg-Lys. They are also antagonistic to acidic FGF.
Patent AU-630376-B2 (AU)
Title: Method for assaying immunologically active substance and reagent therefor
Inventor: SHUTOH SHOICHI
IPC: G01N33/543
Filed: 1989-10-12
Granted: 1992-10-29
Abstract: A method for assaying an immunologically active substance based on the antigen-antibody reaction in a liquid phase, and a reagent for use in the method are disclosed. This method comprises adding a reagent containing a compound represented by the general formula R<1>O-{(CH2CH2O)m(AO)n}-R<2> (wherein R<1> and R<2> each represents a hydrogen atom or a hydrocarbyl group containing 1 to 5 carbon atoms, AO represents an oxyalkylene group containing 3 to 4 carbon atoms, m and n represent the number of oxyethylene groups and that of oxyalkylene groups, respectively, with said oxyethylene groups and oxyalkylene groups forming a random copolycondensate and having a molecular weight of 1000 to 20000, and the ratio of m/n being 60/40 to 90/10).
Patent AU-625802-B2 (AU)
Title: Immunotoxins for the treatment or prophylaxis of auto-immune diseases
Inventor: VERHEUL HERMANUS ANTONIUS MARI
IPC: A61K47/48
Filed: 1989-10-20
Granted: 1992-07-16
Abstract: The present invention concerns epitope cytotoxic substance conjugates for the treatment or prophylaxis of autoimmune diseases. The conjugate specifically binds to auto-immune T-lymphocytes and eliminates the T-lymphocytes responsible for the auto-immune disease.